Coagulation Factors 2011 who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis Product description The report Coagulation Factors 2011 who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis provides a description, evaluation and assessment of the recombinant coagulation factor R&D pipelines as of October 2011. The authors analyze and assess the target pipeline for each of the coagulation factors for haemophilia and work out the target profiles of development projects.
The Cardiovascular Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
The Cardiac Rhythm Management Devices market value is expected to reach US$20.9 billion by 2017, primarily supported by the product types - Cardiac Defibrillators, Cardiac Pacemakers Devices and Cardiac Resynchronization Therapy. Globally, Cardiac Defibrillatorsand Pacemakers Devices together account for approximately 80% of the market share to support the Cardiac Rhythm Management Devices Industry going forward.
Global Inferior Vena Cava (IVC) Filters sector is projected to reach US$435 million by 2016. The North America accounts for nearly 39% (2015) of the global value while Europe claims approximately 27% (2018). Asia-Pacific is the fastest growing region with a CAGR of 13.6% driving a market value of US$99 million by 2015. On a global scale, projections for Retrievable Filters market share indicate more than 60% leaving the rest of the market to the Permanent IVC Filters as a fastest growing sector.
BRICSS Cardiac Resynchronization Therapy (CRT) Devices market value is expected to reach US$455 million by 2016, primarily supported by the product types - Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Cardiac Resynchronization Pacemakers (CRT-P). China accounts for nearly 25% of the market share and India claims more than 23%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Cardiac Resynchronization Therapy Defibrillator (CRT-D) accounts more nearly half of the market value while Cardiac Resynchronization Pacemakers (CRT-P) segments add up to the remaining half.
Point of Care Testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes.
China's demand for Cardiovascular Devices has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades.
This report studies sales (consumption) of Cardiac Resynchronization Therapy Pacemakers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Cardiovascular Devices Market Research Reports
The worldwide market for cardiovascular devices have been displaying signs of rapid expansion with market analysts predicting robust expansion and growth in this segment in future. It is predicted that the global cardiovascular device business will accrue revenue of nearly about ninety seven billion dollars till 2015.
Rising occurrences of cardiovascular diseases and problems among the population all around the globe has boosted the cardiovascular devices market since last few years. As per the American Heart Association, more than eighty millions of population suffer from heart health ailments. Cardiovascular diseases cause more than seventeen million yearly deaths all around the year. Many of the cardiovascular issues can be attributed to forming of wrong food habits and inactive living. As young people eat more foods containing high fat concentration and increasing proportions of sugar, the heart –related incidences are on rise these days.
In fact, heart ailments have been among the major factors accounting for most of the deaths all around the globe and so this aspect adds to the great demand and growth of cardiovascular devices market. This has encouraged the government authorities as well as private firms to invest their capital funds in research, healthcare and surgeries to promote health awareness and state benefits of good heart health among its citizens.
The cardiovascular devices market is divided into two sections named as interventional devices and diagnostic devices. These market sections are likely to amass the total revenues of about sixteen billion and seventy four billion dollars in next few years. Another key section within this business is that of supportive products.
Few of the major products within this section comprise of catheters, drug eluting stents, pacemakers, stents, echocardiography equipment, defibrillators, ventricle support systems, miniature cameras and guide wires.
Acute Market Reports helps you in staying abreast of the current cardiovascular devices market trends. We sell market study reports sourced from the best publishers. Whether you want a worldwide view of the latest market research report of this industry or require geographical location specific market report, we are always there to help & guide you to choose the best of the market research reports of this industry.
Our market reports include present & future market trends, technological trends, end use and end use applications of the cardiovascular devices market represented in the form of pivot tables, graphs, bar diagrams, histograms and Pie or Gantt charts.